Relief Therapeutics Holding AG (RLF.SW) SIX

2.89

+0.025(+0.87%)

Updated at December 16 07:56AM

Currency In CHF

Valuation

Market Cap52.79M
Enterprise Value39.86M
P/E Ratio-2.13
PEG Ratio-0.02
Price/Sales Ratio8.95
Price/Book Ratio1.11
Enterprise/Revenue6.33
Enterprise/EBITDA-1.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-4.2
Operating Margin-2.05

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.49

Income Statement

Revenue8.42M
Revenue/Share0.32
Gross Profit5.84M
EBITDA-16.73M
Net Income-17.12M
Diluted EPS-1.36

Balance Sheet

Total Cash12.5M
Total Cash/Share1
Total Debt1.9M
Total Debt/Equity0.06
Current Ratio4.05
Book Value Per Share2.6

Price History

52-Week Change-35.17
52-Week High4.59
52-Week Low1.65
Moving Average 50 Days2.91
Moving Average 200 Days2.61

Statistics

Average Volume41,210
Shares Outstanding12.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:400
Last Split DateMay 05, 2023